Decelerating growth and heavy capex make sustained high revenue and FCF margins unrealistic for TransMedics. Read why TMDX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results